Exceeded Contracted Enrollment Goal in Phase 2 Rare Disease Study

As the top enrolling site among 52 research locations, Science 37 enrolled 21% of all study participants—11x faster than traditional brick-and-mortar sites. The sponsor expanded Science 37’s contracted capacity after the team exceeded initial enrollment projections.